Prof. dr. D. Morton
School of Cancer Sciences (University of Birmingham), Academic Department of Surgery, Birmingham
Verenigd Koninkrijk
About
Dion received his degree in Medicine from Bristol University in 1985. He was awarded an MD from Bristol University in 1993 and was appointed a Lecturer at Birmingham University in the same year. He was given an honorary consultant appointment at the University Hospital Birmingham in 1996. He was appointed Professor of Surgery in 2006. For the National Institute for Health Research (NIHR), he chairs the National Working Party for Recruitment into interventional trials. He also chairs the National Cancer Research Institute (NCRI) Surgical Colorectal Subgroup. His research interests are predominantly in clinical and translational research in colorectal cancer, but also encompassing the development of clinical trials in surgery. He leads a portfolio of national trials in colorectal cancer and research into cancer prevention and is the Director of the Birmingham Experimental Cancer Medicine Centre (ECMC).
YouTube
Qualifications
MBChB 1985, Bristol
FRCS (Eng), 1989, Bristol
MD, 1994, Bristol
Teaching
Dion undertakes two fixed undergraduate (clinical) teaching sessions per week and instructs students during his outpatient, endoscopy, and theatre sessions. He give lectures to both the dental and medical students, as well as providing small group teaching sessions and revision courses in surgery. Dion also runs an annual course on Colorectal Cancer Prevention at the University of Birmingham.
Publications
1. Walker M, O'Sullivan B, Perakath B, Taniere P, Cruger D, Morton D. Selecting patients with young-onset colorectal cancer for mismatch repair gene analysis. Br J Surg. 2007 Dec;94(12):1567-71.
2. K. Y. Khan, T. Xiong, I. McCafferty, P. Riley, P. Guest, S. Radley, T. Ismail, R. Lilford, DG. Morton. CT Colonography: The Impact and Frequency of Extracolonic Findings in a Symptomatic Population. Br J Surg 2007 Mar;94(3):355-61
3. Caldwell GM, Jones CE, Soon Y, Warrack R, Morton DG, Matthews GM. Reorganisation of the Wnt response pathway in colorectal carcinogenesis. Br J Cancer, 2008 Apr 22;98(8): 1437-42
4. Baron JA, Sandler RS, Bresalier RS, Lanas A, Morton DG, Riddell R, Iverson ER, Demets DL. Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet. 2008 Nov 15;372(9651):1756-64.
5. Von Wagner C, Knight K, Halligan S, Atkin W, Lilford R, Morton D, Wardle J. Patient experiences of colonoscopy, barium enema and CT colonography: a qualitative study. Br J Radiol. 2009 Jan;82(973):13-9.]
6. UK Flexible Sigmoidoscopy Trial Investigators: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet.2010 May 8;375(9726):1624-33.Epub 2010 Apr 27.
7. Caldwell G, Jones CE, Ashley AM, Wei W, Hedmadi RK, Morton DG, Matthews G. Wnt signalling in adenomas of FAP patients. Br J Cancer 2010 Sep 103, 910–917
8. Chughtai S, Crundwell M, Cruickshank N, Knowles M, Luscombe M, Neoptolemos J, Morton D. Three regions of interstitial deletion on chromosome 8 in colorectal cancers. Br J Surg 1996;83:1624.
9. Lanas A, Baron JA, Sandler RS, Horgan K, Bolognese J, Oxenius B, Quan H, Watson D, Cook TJ, Schoen R, Burke C, Loftus S, Niv Y, Ridell R, Morton D, Bresalier R. Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial. Gastroenterology. 2007 Feb;132(2):490-7.